Pet Anthelmintic Drugs Market 2028 By Target Pathogen, Distribution Channel | The Insight Partners

report image

Pet Anthelmintic Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Target Pathogen (Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], Others); Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals and Clinics)

Report Code: TIPRE00013986 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Anthelmintics are drugs that are used to treat infections with parasitic worms. This includes both flat worms, e.g., flukes and tapeworms and round worms, i.e., nematodes. They are of huge importance for veterinary medicine.


The pet anthelmintic drugs market is driving due to the increasing prevalence of rise in prevalence of helminth infections caused by roundworm, hookworm, whipworm, and others worms. However, rise in drug resistance to most commonly prescribed anthelmintic drugs may impede the market growth in the review period.


The "Pet Anthelmintic Drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet anthelmintic drugs market with detailed market segmentation by target pathogen, and distribution channel. The pet anthelmintic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pet anthelmintic drugs market and offers key trends and opportunities in the market.


The pet anthelmintic drugs market is segmented on the basis of target pathogen, and distribution channel. On the basis of target pathogen, the market is categorized as ascaris lumbricoides [roundworm], trichuris trichiura [whipworm], enterobius vermicularis [pinworm], ancylostoma duodenale [hookworm], and others. On the basis of distribution channel, the market is categorized as veterinary pharmacies, and veterinary hospitals and clinics.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet anthelmintic drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet anthelmintic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pet anthelmintic drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the pet anthelmintic drugs market in these regions.

Get more information on this report :


The report covers key developments in the pet anthelmintic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet anthelmintic drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet anthelmintic drugs in the global market. Below mentioned is the list of few companies engaged in the pet anthelmintic drugs market.

The report also includes the profiles of key players in pet anthelmintic drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novartis AG
  •  Cipla Inc.
  •  Sun Pharmaceutical Industries Ltd
  •  Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
  •  Zoetis, Inc.
  •  GlaxoSmithKline plc
  •  Bayer AG
  •  Merck & Co., Inc. (Intervet Inc.)
  •  Boehringer Ingelheim International GmbH
  •  Virbac

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Novartis AG
2. Cipla Inc.
3. Sun Pharmaceutical Industries Ltd
4. Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
5. Zoetis, Inc.
6. GlaxoSmithKline plc
7. Bayer AG
8. Merck & Co., Inc. (Intervet Inc.)
9. Boehringer Ingelheim International GmbH
10. Virbac

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount